- Home
- ABEO vs CLPT Comparison
ABEO vs CLPT Comparison
Compare ABEO & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | CLPT |
|---|---|---|
| Founded | 1974 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.5M | 353.5M |
| IPO Year | 2005 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ABEO | CLPT |
|---|---|---|
| Price | $5.53 | $13.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $20.00 | $20.00 |
| AVG Volume (30 Days) | ★ 918.3K | 545.4K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,998,000.00 | ★ $36,971,000.00 |
| Revenue This Year | $1,024.31 | $45.67 |
| Revenue Next Year | $145.42 | $19.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 258.18 | 17.78 |
| 52 Week Low | $4.00 | $8.27 |
| 52 Week High | $7.54 | $30.10 |
Technical Indicators
Market Signals| Indicator | ABEO | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 51.58 | 54.84 |
| Support Level | $5.24 | $12.87 |
| Resistance Level | $5.64 | $13.59 |
| Average True Range (ATR) | 0.23 | 1.02 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 47.52 | 48.45 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.